Features Biotechnology

Charles Berkman – Ligand Pharmaceuticals

It seemed like just another morning—until employees got to their desks to find pudding cups with a note reading: “The proof is in the pudding.” To explain: The day before, incoming Ligand Pharmaceuticals CEO John Higgins gave a speech to employees about his philosophy, his goals for the company and the “period of high change” […]

Keary Dunn – Celularity

Keary Dunn recognized early on the opportunities and implications of immunotherapy and cellular therapy. As new BS graduate and young neuropharmacology lab technician at Georgetown University, he undertook cutting edge science research. Specifically, he studied the effects of cocaine and heroin on the immune system, testing the theory—on mice—that such narcotics suppressed the body’s greatest […]

Nicholas McGrath – MPM Capital

It’s a different type of executive team that Nicholas McGrath interacts with as general counsel and chief compliance officer of MPM Capital, a life sciences venture capital firm with offices in Cambridge, Massachusetts, and Brisbane, California. Doctorates and medical degrees, not master’s in business administration, bestow the investment professionals employed at the company. That’s the […]

Jim Kastenmayer – Viela Bio

Imagine strolling through a park splashed with the greens, yellows and reds of trees, grass and flowers. The gravel or woodchips crunch underfoot as you enjoy exercise, sunshine and good health. And suddenly, you can’t see well or have trouble walking. It could be an attack of a terrifying and debilitating condition called neuromyelitis optica […]

Jeffrey C. Pepe – Silverback Therapeutics

Talk to Jeffrey C. Pepe and it’s obvious he’s as much scientist as legal boss of Seattle-based biopharmaceutical startup Silverback Therapeutics, advancing potent first-in-kind immunotherapies. He’ll put in layman’s terms the complex immunotherapies Silverback anticipates bringing into the clinic later this year. If all goes well—and that’s an issue considering how COVID-19 threatens to set […]

Shawnte Mitchell – Aptevo Therapeutics

Will the data provide strong, tangible results or prove inconclusive? Will patients feel positive, negative or no side effects? And, most essentially, will the new therapies serve as a cure for the insidious disease that is cancer? Right now is a critical time for Aptevo Therapeutics and its several oncology therapies. With many potential treatments […]

Testimonials

As promised in advance, my feature in Vanguard has increased my visibility within the profession and prompted more than a few people I have not communicated with recently to reconnect. One of the Italian law firms I have used in the past is now in the process of interviewing me for an article on their website and tweeting out the feature story. Activity and the number of people connecting with me on LinkedIn has soared, which is great. The Vanguard writers and editorial staff were great to work with—highly professional and made the effort to make the experience both fun and rewarding (they were also respectful of the time pressures and demands all lawyers face). I was very pleased with the experience and the final outcome. Needless to say, I have been very pleased. All in all working with Vanguard has been a very positive experience which generated good publicity for both Shawcor and myself. My sincere thanks.
– Tim Hutzul, General Counsel, ShawCor Ltd.
The piece highlighting my company, Bob Baker Enterprises, Inc., came out fabulous. Our company is in the new and used car sales and service industry. Everyone was great to work with and extremely professional. They produced a high-quality product and have provided expert assistance and guidance post-production of the article.
– Wade Poulson, General Counsel, Bob Baker Enterprises Inc.
I was honored to be the subject of an article. I enjoy reading Vanguard articles and seeing how other attorneys got to their positions and see their jobs. It's also interesting to see how different law firms partner with the subjects of the articles.
– Henry Marquard, in-house counsel, Stanley Consultants Inc.
It was a great honor to be featured in Vanguard Law. Working with every member of the team, from the initial interview with Erin Clark, through production with Victor Martins, writing the article with Taryn Plumb and creating the final content with Dave Gushee, was a true pleasure. Everyone was very professional, enthusiastic and supportive, and their creative approach and positive attitude clearly came through in the final product.
– Kevin C. Rakowski, Senior Vice President, Deputy General Counsel, Compliance with Radian Group Inc.

LATEST EDITION

Fall IV 2020

READ NOW

GET VANGUARD IN YOUR INBOX.

  • * We’ll never share your email or info with anyone.
  • This field is for validation purposes and should be left unchanged.